Used primarily in research settings as a selective inhibitor of the PI3K p110β isoform, TGX-221 helps investigate signaling pathways involved in cell growth, survival, and metabolism. It is valuable in studying cancer cell proliferation, particularly in tumors where PI3K pathway activation plays a key role. Researchers also use it to explore insulin signaling and platelet function, as PI3Kβ is involved in thrombosis, making TGX-221 a tool compound for assessing potential antithrombotic therapies. Its selectivity allows for targeted pathway modulation without broad inhibition of related kinases.